Patient Performance on Virtual Reality Visual Field Devices as Compared to Standard of Care

University of Miami1 site in 1 country287 target enrollmentOctober 30, 2021

ConditionsGlaucoma

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Glaucoma
Sponsor: University of Miami
Enrollment: 287
Locations: 1
Primary Endpoint: Specificity of VRVF compared to SAP
Status: Completed
Last Updated: last year

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of this research is to study the effectiveness and patient experience when measuring visual fields using virtual reality goggles.

Registry

clinicaltrials.gov

Start Date

October 30, 2021

End Date

June 21, 2024

Last Updated

last year

Study Type

Observational

Sex

All

Investigators

Sponsor

University of Miami

Responsible Party

Principal Investigator

Elena Bitrian

Associate Professor of Clinical

University of Miami

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Outcomes

Primary Outcomes

Specificity of VRVF compared to SAP

Time Frame: Day 1

Specificity of VRVF will be determined by comparing Hodapp Anderson Parrish (HAP) Scores, which assess the severity of visual field defects, to those of SAP

Sensitivity of VRVF compared to SAP

Time Frame: Day 1

Sensitivity of VRVF will be determined by comparing Hodapp Anderson Parrish (HAP) Scores, which assess the severity of visual field defects, to those of SAP